Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression

References

• Mozaffarian D, Benjamin EJ, Go AS, et al., Stroke Statistics Subcommittee. Heart disease and stroke statistics-2016 Update: a report from the American Heart Association. Circulation. 2016;133:e38–e48.
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135:759–771.
   PubMed Web of Science ®Google Scholar
• Jing L, Wang JG, Zhang JZ, et al. Upregulation of ICAM-1 in diabetic rats after transient forebrain ischemia and reperfusion injury. J Inflamm. 2014;11:35.
   Google Scholar
• Appiah KO, Minhas JS, Robinson TG. Managing high blood pressure during acute ischemic stroke and intracerebral hemorrhage. Curr Opin Neurol. 2018;31:8–13.
   PubMed Web of Science ®Google Scholar
• Keller K, Geyer M, Münzel T, et al. Impact of atrial fibrillation on in-hospital mortality of ischemic stroke patients and identification of promoting factors of atrial thrombi – results from the German nationwide inpatient sample and a single-center retrospective cohort. Medicine. 2019;98:e14086.
   PubMed Web of Science ®Google Scholar
• Kawada T. Obstructive sleep apnea and ischemic stroke: a risk assessment. Neurol Sci. 2019;40:2183.
   PubMed Web of Science ®Google Scholar
• Jian-Wen Z, Ping W, Chao R, et al. Advance in mechanism study of inflammation in post-ischemic stroke and opportunity of new drug development. Chin Pharm Bull. 2019;35:468–473.
   Google Scholar
• Paul Kamdem J, Olalekan Abolaji A, Olusola Elekofehinti O, et al. Therapeutic potential of plant extracts and phytochemicals against brain ischemia-reperfusion injury: a review. NPJ. 2016;6:250–284.
   Google Scholar
• Tamura T, Aoyama M, Ukai S, et al. Neuroprotective erythropoietin attenuates microglial activation, including morphological changes, phagocytosis, and cytokine production. Brain Res. 2017; 1662:65–74.
   PubMed Web of Science ®Google Scholar
• Jeong JE, Park JH, Kim CS, et al. Neuroprotective effects of erythropoietin against hypoxic injury via modulation of the mitogen-activated protein kinase pathway and apoptosis. Korean J Pediatr. 2017;60:181.
   PubMedGoogle Scholar
• Xie Z, Zhou Y, Duan X, et al. Inhibitory effect of tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress. J Recept Res. 2019;39:1–12.
   Google Scholar
• Ding C, Chen H, Liang B, et al. Biomimetic synthesis of the natural product salviadione and its hybrids: discovery of tissue-specific anti-inflammatory agents for acute lung injury. Chem Sci. 2019;10:4667–4672.
   PubMed Web of Science ®Google Scholar
• Nan L, Liang Y, Baolian Z, et al. Tanshinone IIA effects on ovarian cancer cell line. J Pharm Pharmacol. 2018;70:1369–1377.
   PubMed Web of Science ®Google Scholar
• Ji B, Zhou F, Han L, et al. Sodium tanshinone IIA sulfonate enhances effectiveness Rt-PA treatment in acute ischemic stroke patients associated with ameliorating blood-brain barrier damage. Transl Stroke Res. 2017;8:334– 337.
   PubMed Web of Science ®Google Scholar
• Li Y, Dang Y, Han D, et al. An Angiopep-2 functionalized nanoformulation enhances brain accumulation of tanshinone IIA and exerts neuroprotective effects against ischemic stroke. New J Chem. 2018;42:17359–17370.
   Web of Science ®Google Scholar
• Liu LL, Liu H, Yin JL, et al. Protective effect of tanshinone IIA during the acute stage of focal cerebral ischemia in rats. Chin J Stroke. 2014;9:20–25.
   PubMedGoogle Scholar
• Liang XL, Zhu ML, Cao YC, et al. Preparation, characterization evaluation of tanshinone IIA lipid microspere and comparative study of pharmacokinetics with sodium tanshinone IIA sulfonate injection. AMR. 2013;781-784:1044–1051.
   Google Scholar
• Liu HC, Liu HH. Adverse reactions of tanshinone II(A) sodium sulfonate injection in treating 18 cases: an analysis of clinical features. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013;33:1287–1289.
   PubMedGoogle Scholar
• Muir KW, Tyrrell P, Sattar N, et al. Inflammation and ischaemic stroke. Curr Opin Neurol. 2007;20:334–342.
   PubMed Web of Science ®Google Scholar
• Mizuma A, Yenari MA. Anti-inflammatory targets for the treatment of reperfusion injury in stroke. Front Neurol. 2017;8:467.
   PubMed Web of Science ®Google Scholar
• Campanella M, Sciorati C, Tarozzo G, et al. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke. 2002; 33:586–592.
   PubMed Web of Science ®Google Scholar
• Kozuka K, Kohriyama T, Nomura E, et al. Endothelial markers and adhesion molecules in acute ischemic stroke-sequential change and differences in stroke subtype. Atherosclerosis. 2002;161:161–168.
   PubMed Web of Science ®Google Scholar
• Chapman KZ, Ge R, Monni E, et al. Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke. Neurobiol Dis. 2015;83:1–15.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kawabori M, Yenari MA. Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem. 2014;21:2076–2097.
   PubMed Web of Science ®Google Scholar
• Vieira DB, Gamarra LF. Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier. Int J Nanomedicine. 2016;11:5381–5414.
   PubMed Web of Science ®Google Scholar
• Rip J. Liposome technologies and drug delivery to the CNS. Drug Discov Today Technol. 2016;20:53–58.
   PubMedGoogle Scholar
• Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30:592–599.
   PubMed Web of Science ®Google Scholar
• Li N, Feng L, Tan Y, et al. Preparation, characterization, pharmacokinetics and biodistribution of baicalin-loaded liposome on cerebral ischemia-reperfusion after i.v. administration in rats. Molecules. 2018;23:1747.
   Web of Science ®Google Scholar
• Wang J, Cai J, Wang X, et al. An injectable liposome for sustained release of tanshinone IIA to the treatment of acute blunt muscle injury by augmenting autophagy and alleviating oxidative stress. Am J Transl Res. 2020;12:4189–4203.
   PubMed Web of Science ®Google Scholar
• Lin J, Wang X, Wu Q, et al. Development of salvianolic acid B-tanshinone II A-glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells. Int J Pharm. 2014;462:11–18.
   PubMed Web of Science ®Google Scholar
• Cheng C, Liu XW, Du FF, et al. Sensitive assay for measurement of volatile borneol, isoborneol, and the metabolite camphor in rat pharmacokinetic study of Borneolum (Bingpian) and Borneolum syntheticum (synthetic Bingpian). Acta Pharmacol Sin. 2013;34:1337–1348.
   PubMed Web of Science ®Google Scholar
• Cai Z, Hou S, Li Y, et al. Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target. 2008;16:178–184.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145–160.
   PubMed Web of Science ®Google Scholar
• Jin WY, Lin SL, Hou RL, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth. 2016;16:60.
   PubMed Web of Science ®Google Scholar
• Schaller B, Graf R. Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab. 2004;24:351–371.
   PubMed Web of Science ®Google Scholar
• Siniscalchi A, Gallelli L, Malferrari G, et al. Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol. 2014;25:131–137.
   PubMedGoogle Scholar
• Howard EF, Chen Q, Cheng C, et al. NF-kappa B is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neurosci Lett. 1998;248:199–203.
   PubMed Web of Science ®Google Scholar
• Joseph F, Marie L, Dragan M, et al. Circulating CD133 + CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients. J Transl Med. 2011;9:1–7.
   Web of Science ®Google Scholar
• Cheng Z, Wang L, Qu M, et al. Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. J Neuroinflammation. 2018;15:135.
   PubMed Web of Science ®Google Scholar
• Li W, Suwanwela NC, Patumraj S. Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF-κB, ICAM-1, MMP-9 and caspase-3 expression. Mol Med Rep. 2017;16:4710–4720.
   PubMed Web of Science ®Google Scholar
• Lindsberg PJ, Carpén O, Paetau A, et al. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation. 1996;94:939–945.
   PubMed Web of Science ®Google Scholar